FDAnews
www.fdanews.com/articles/158168-chiesi-group-acquires-zymenex-enters-rare-disease-market

Chiesi Group Acquires Zymenex, Enters Rare-Disease Market

August 27, 2013
Chiesi is purchasing Zymenex and related companies in an effort to enter the rare disease market.
Genetic Engineering & Biotechnology News